SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-786342
Filing Date
2016-12-06
Accepted
2016-12-06 16:30:56
Documents
5
Period of Report
2016-12-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d288381d8k.htm 8-K 15030
2 EX-99.1 d288381dex991.htm EX-99.1 35001
3 EX-99.2 d288381dex992.htm EX-99.2 19130
4 EX-99.3 d288381dex993.htm EX-99.3 38576
5 GRAPHIC g288381g1206114123639.jpg GRAPHIC 3664
  Complete submission text file 0001193125-16-786342.txt   114049
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 162036648
SIC: 2834 Pharmaceutical Preparations